[go: up one dir, main page]

AU1621501A - Methods and compositions for treatment of disease - Google Patents

Methods and compositions for treatment of disease

Info

Publication number
AU1621501A
AU1621501A AU16215/01A AU1621501A AU1621501A AU 1621501 A AU1621501 A AU 1621501A AU 16215/01 A AU16215/01 A AU 16215/01A AU 1621501 A AU1621501 A AU 1621501A AU 1621501 A AU1621501 A AU 1621501A
Authority
AU
Australia
Prior art keywords
disease
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16215/01A
Inventor
Robert J. Harrison
John R. Murphy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agricen LLC
Original Assignee
Agricen LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricen LLC filed Critical Agricen LLC
Publication of AU1621501A publication Critical patent/AU1621501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/345—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Brevibacterium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU16215/01A 1999-11-19 2000-11-20 Methods and compositions for treatment of disease Abandoned AU1621501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16660099P 1999-11-19 1999-11-19
US60166600 1999-11-19
PCT/US2000/031721 WO2001035981A1 (en) 1999-11-19 2000-11-20 Methods and compositions for treatment of disease

Publications (1)

Publication Number Publication Date
AU1621501A true AU1621501A (en) 2001-05-30

Family

ID=22603978

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16215/01A Abandoned AU1621501A (en) 1999-11-19 2000-11-20 Methods and compositions for treatment of disease

Country Status (3)

Country Link
AU (1) AU1621501A (en)
CA (1) CA2389566A1 (en)
WO (1) WO2001035981A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006034134A2 (en) 2004-09-20 2006-03-30 Boston Medical Center Corporation Antibacterial peptide with activity against b. anthracis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599537A (en) * 1990-12-18 1997-02-04 The General Hospital Corporation Salmonella virulence genes
US5942532A (en) * 1997-09-05 1999-08-24 Ortho Pharmaceutical Corporation 2-substituted phenyl-benzimidazole antibacterial agents
EP1117773A4 (en) * 1998-09-30 2005-11-16 Millennium Pharm Inc Secreted proteins and nucleic acids encoding them

Also Published As

Publication number Publication date
WO2001035981A1 (en) 2001-05-25
CA2389566A1 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
AUPR638101A0 (en) Composition and method for treatment of disease
AU3998400A (en) Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU7748000A (en) Method and composition for the treatment of dermatologic diseases
AUPQ415899A0 (en) Compositions for and methods of treatment of allergic diseases
AU7743100A (en) Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
AU3469400A (en) Pharmaceutical compositions for treatment of diseased tissues
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU3896900A (en) Treatment of pain
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
AU1878201A (en) Composition for the treatment of damaged tissue
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2001232345A1 (en) Compositions for preventing and treating digestive diseases
AUPP870999A0 (en) Method of treatment of equine disease
AU3356000A (en) L-arginine based formulations for treating diseases and methods of using same
AU2420101A (en) Method and composition for the treatment of pain
AU2566201A (en) Compounds and methods for the treatment of pain
AU4034800A (en) Novel compositions and methods for prevention and treatment of protozoal disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase